Atlas Trials

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

Clinical trial NCT00926640 · COMPLETED

Trial details

NCT number
NCT00926640
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Carcinoma NeuroendocrineSmall Cell Lung CarcinomaMalignant Epithelial Neoplasms
Start date
2009-07-01
Primary completion
2017-06-16
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.